Application of agents of anti-PD-L1 antibody in advanced tumor therapy / 国际肿瘤学杂志
Journal of International Oncology
;
(12): 296-298, 2016.
Artículo
en Chino
| WPRIM
| ID: wpr-493141
ABSTRACT
Programmed death-1 (PD-1) and its ligand 1 (PD-L1) play critical roles in the identification and elimination of tumor cells evading the host's immune system.Tumor model in mice which is given anti-PD-L1 monoclonal antibody shows obviously host anti-tumor response.Currently,immunotherapy drugs of PD-1/PD-L1 signaling pathways receive good effects in a variety of tumors failure of the traditional method,and with less adverse reaction,which provide valuable clinical experiences in advanced tumor immunotherapy.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Journal of International Oncology
Año:
2016
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS